NRC HEALTH
NRCNasdaq
$21.78
↓ -0.7%Jul 17 close · end-of-day
Price
1Y↑ +50.8%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$477.2M
Enterprise Value
$548.7M
P/E
0.4
P/S
3.4
P/B
35.4
EV/EBITDA
19.7
PEG
0.0
FCF Yield
3.6%
Dividend Yield
2.6%
Revenue (TTM)
$138.6M
Net Income (TTM)
—
Free Cash Flow (TTM)
$17.4M
Gross Margin
—
Operating Margin
14.1%
Net Margin
—
ROE
—
ROIC
14.3%
Debt / Equity
5.5
Net Cash
-$71.5M
Return 1Y
+50.8%
Company profile
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty.
- CEO
- Michael D. Hays
- Sector
- Services
- Industry
- Business Services
- Employees
- 490
- Headquarters
- Nebraska
- Website
- nrchealth.com
Management & directors
- Rau Jason RussellExecutive Vice President
- Harrison Shane REVP & Chief Financial Officer
- Burik DavidEVP, Strategic Insights
- Hays Michael D.Chairman
- Hrdy HelenEVP & Chief Operating Officer
- Freeman Jordan NicoleChief Accounting Officer
Roles derived from SEC Form 4 filings.
Earnings
NRC Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$34.8M↑ +3.7%
Diluted EPS$0.14↓ -44.0%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $133.3M | $148.0M | $151.6M | $148.6M | $143.1M | $137.4M |
| Gross profit | — | — | — | — | — | — |
| Operating income | $42.7M | $50.3M | $46.5M | $40.0M | $35.2M | $22.6M |
| Net income | — | $37.5M | $31.8M | $31.0M | $24.8M | $11.6M |
| Diluted EPS | $1.45 | $1.46 | $1.27 | $1.25 | $1.04 | $50.00 |
| Operating cash flow | $40.6M | $46.3M | $36.3M | $38.1M | $34.6M | $26.4M |
| Free cash flow | $36.7M | $40.8M | $26.4M | $22.3M | $19.2M | $15.7M |
| Gross margin | — | — | — | — | — | — |
| Operating margin | 32.0% | 34.0% | 30.7% | 27.0% | 24.6% | 16.4% |
| Net margin | — | 25.3% | 21.0% | 20.8% | 17.3% | 8.4% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $35.0M | $35.8M | $36.9M | $33.6M | $34.0M | $34.6M | $35.2M | $34.8M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $8.9M | $8.0M | $9.6M | $8.6M | $1.6M | $7.7M | $4.7M | $5.6M |
| Net income | — | — | — | — | — | — | — | — |
| Diluted EPS | $0.26 | $0.24 | $0.27 | $0.25 | -$0.01 | $0.18 | $49.58 | $0.14 |
| Operating cash flow | $6.8M | $9.4M | $6.4M | $6.6M | -$1.1M | $13.8M | $7.2M | $7.2M |
| Free cash flow | $1.5M | $7.8M | $1.9M | $3.7M | -$4.1M | $10.2M | $6.1M | $5.3M |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | 25.3% | 22.3% | 26.0% | 25.6% | 4.7% | 22.4% | 13.3% | 16.0% |
| Net margin | — | — | — | — | — | — | — | — |
Company news
May 28, 2026
May 13, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-23 | Berwick Donald M | Award | 7,697 | $0.00 | $0.00 | filing |
| 2026-06-23 | Bhandari Parul | Award | 7,697 | $0.00 | $0.00 | filing |
| 2026-06-23 | Lockhart Stephen H | Award | 7,697 | $0.00 | $0.00 | filing |
| 2026-06-23 | NUNNELLY JOHN N | Award | 7,697 | $0.00 | $0.00 | filing |
| 2026-06-23 | Wheeler Penny Ann | Award | 7,697 | $0.00 | $0.00 | filing |
| 2026-03-12 | Rau Jason Russell· Executive Vice President | Award | 60,000 | $0.00 | $0.00 | filing |
| 2026-02-17 | HARRISON SHANE R· EVP & Chief Financial Officer | Buy | 8,000 | $12.27 | $98,162.40 | filing |
| 2026-01-05 | Hays Michael D.· Chairman | Option exercise | 9,145 | $15.23 | $139,278.35 | filing |
| 2026-01-05 | Burik David· EVP, Strategic Insights | Award | 100,000 | $0.00 | $0.00 | filing |
| 2025-12-29 | HARRISON SHANE R· EVP & Chief Financial Officer | Tax withholding | 21,271 | $18.66 | $396,916.86 | filing |
| 2025-12-15 | Hrdy Helen· EVP & Chief Operating Officer | Tax withholding | 11,244 | $17.64 | $198,344.16 | filing |
| 2025-12-15 | Hrdy Helen· EVP & Chief Operating Officer | Option exercise | 12,346 | $15.23 | $188,029.58 | filing |
| 2025-09-29 | HARRISON SHANE R· EVP & Chief Financial Officer | Award | 172,000 | $0.00 | $0.00 | filing |
| 2025-07-31 | Freeman Jordan Nicole· Chief Accounting Officer | Buy | 771 | $12.97 | $9,999.87 | filing |
Latest 14 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.